Liver-kidney transplantation to cure atypical hemolytic uremic syndrome

Journal of the American Society of Nephrology

Volumn 20, Issue 5, 2009, Pages 940-949

  Saland, Jeffrey M ^r   Ruggenenti, Piero ^d   Remuzzi, Giuseppe ^a   Bekassy, Zivile ^b   Bensman, Albert ^c   Bresin, Elena ^d   Colledan, Michele ^e   Camilla, Roberta ^f   Coppo, Rosanna ^f   Cruzado Garrit, Jose Maria ^g   Daina, Erica ^d   Fremeaux Bacchi, Veronique ^h   Goodship, Timothy J ⁱ   Gridelli, Bruno ^j   Hugo, Christian ^k   Karpman, Diana ^l   Jalanko, Hannu ^m   Loirat, Chantal ⁿ   Hijosa, Marta Melgosa ^o   Mc Kiernan, Pat J ^p   Noris, Marina ^d   De Cordoba, Santiago Rodriguez ^q   Rota, Giovanni ^e   Sanchez Corral, Pilar ^o   Skerka, Christine ^s   Tartufari, Adriana ^e   Zipfel, Peter F ^s   more..

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d Clinic Res Ctr for Rare Diseases   (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l LUND UNIVERSITY   (Sweden)

^m HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁿ HÔPITAL ROBERT DEBRÉ   (France)

^o HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^p BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^q CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^r MOUNT SINAI MEDICAL CENTER   (United States)

^s HANS KNÖLL INSTITUTE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCINEURIN INHIBITOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; ENOXAPARIN; REGULATOR PROTEIN;

ANTICOAGULATION; GENE MUTATION; GENETIC ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NEPHRECTOMY; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; GENETICS; HEMOLYTIC ANEMIA; KIDNEY DISEASE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MUTATION; PRACTICE GUIDELINE; THROMBOCYTOPENIA;

ANEMIA, HEMOLYTIC; COMBINED MODALITY THERAPY; COMPLEMENT FACTOR H; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MUTATION; PRACTICE GUIDELINES AS TOPIC; THROMBOCYTOPENIA;

EID: 65649106258     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008080906     Document Type: Review

References (48)

1. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB:Aclassification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70: 423-431, 2006 (Pubitemid 44141568)
2. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Goodship TH, Remuzzi G: Outcome of patients with non-Shiga toxin-associated HUS: Prognostic significance of genetic background. Clin J Am Soc Nephrol 1: 88-99, 2006
3. Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, Goodship JA, Fremeaux-Bacchi V, Remuzzi G, Goodship TH, Atkinson JP: Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol 45: 95-105, 2008 (Pubitemid 47336973)
4. Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM: A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol 44: 1835-1844, 2007
5. Geelen J, van den Dries K, Roos A, van de Kar N, de Kat Angelino C, Klasen I, Monnens L, van den Heuvel L: A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome. Pediatr Nephrol 22: 371-375, 2007 (Pubitemid 46766761)
6. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH: Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41: e84, 2004
7. Fremeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP: Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood September 16, 2008 [epub ahead of print]
8. Goicoechea de Jorge E, Harris CL, Esparza- Gordillo J, Carreras L, Arranz EA, Garrido CA, Lopez-Trascasa M, Sanchez-Corral P, Morgan BP, Rodriguez de Cordoba S: Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 104: 240-245, 2007 (Pubitemid 46068016)
9. Jozsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C: Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 111: 1512-1514, 2008
10. Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G: Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108: 1267-1279, 2006 (Pubitemid 44232024)
11. Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, Taylor CM, Goodship TJ, Noris M: Where next with atypical hemolytic uremic syndrome? Mol Immunol 44: 3889-3900, 2007 (Pubitemid 47337120)
12. Pichette V, Querin S, Schurch W, Brun G, Lehner-Netsch G, Delage JM: Familial hemolytic- uremic syndrome and homozygous factor H deficiency. Am J Kidney Dis 24: 936-941, 1994 (Pubitemid 24380466)
13. Kavanagh D, Goodship TH: Update on evaluating complement in hemolytic uremic syndrome. Curr Opin Nephrol Hypertens 16: 565-571, 2007 (Pubitemid 350293750)
14. Loirat C, Niaudet P: The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18: 1095-1101, 2003 (Pubitemid 37406854)
15. Miller RB, Burke BA, Schmidt WJ, Gillingham KJ, Matas AJ, Mauer M, Kashtan CE: Recurrence of haemolytic-uraemic syndrome in renal transplants: A single-centre report. Nephrol Dial Transplant 12: 1425-1430, 1997 (Pubitemid 27353034)
16. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M: Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12: 3385-3395, 2003 (Pubitemid 37541083)
17. Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender BU, Cybulla M, Riegler P, Konigsrainer A, Neyer U, Bock A, Widmer U, Male DA, Franke G, Zipfel PF: Haemolytic uraemic syndrome and mutations of the factor H gene: A registry- based study of German speaking countries. J Med Genet 40: 676-681, 2003 (Pubitemid 37100700)
18. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP: Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17: 2017-2025, 2006 (Pubitemid 44036186)
19. Seitz B, Albano L, Vocila F, Mzoughi S, Aoudia R, Guitard J, Ribes D, Vachet-Copponat H, Mourad G, Bienaime F, Dahan P, Fremeaux-Bacchi V, Cassuto E: Recurrence of hemolytic uremic syndrome after renal transplantation. Transplant Proc 39: 2583-2585, 2007 (Pubitemid 47588386)
20. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C: Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18: 2392-2400, 2007 (Pubitemid 47203855)
21. Cheong HI, Lee BS, Kang HG, Hahn H, Ha IS, Choi Y, Suh KS: Treatment of factor H (FH) deficiency-associated atypical hemolytic uremic syndrome (HUS) with liver transplantation- a case report (abstract). J Am Soc Nephrol 12: 550A, 2001
22. Cheong HI, Lee BS, Kang HG, Hahn H, Suh KS, Ha IS, Choi Y: Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 19: 454-458, 2004 (Pubitemid 38477414)
23. Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B: Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359: 1671-1672, 2002 (Pubitemid 34518531)
24. Remuzzi G, Ruggenenti P, Colledan M, Gridelli B, Bertani A, Bettinaglio P, Bucchioni S, Sonzogni A, Bonanomi E, Sonzogni V, Platt JL, Perico N, Noris M: Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am J Transplant 5: 1146-1150, 2005 (Pubitemid 40571267)
25. Saland JM, Emre SH, Shneider BL, Benchimol C, Ames S, Bromberg JS, Remuzzi G, Strain L, Goodship TH: Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 6: 1948-1952, 2006 (Pubitemid 44024968)
26. Saland JM, Shneider BL, Bromberg JS, Shi PA, Ward SC, Magid MS, Benchimol C, Seikaly MG, Emre SH, Bresin E, Remuzzi G: Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol November 12, 2008 [epub ahead of print]
27. Jalanko H, Peltonen S, Koskinen A, Puntila J, Isoniemi H, Holmberg C, Pinomaki A, Armstrong E, Koivusalo A, Tukiainen E, Makisalo H, Saland J, Remuzzi G, de Cordoba S, Lassila R, Meri S, Jokiranta TS: Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 8: 216-221, 2008
28. Ariceta G, Besbas N, Johnson S, Karpman D, Landau G, Licht C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB, European Paediatric Study Group for HUS: Guideline for the investigation and initial therapy of diarrhea negative haemolytic uraemic syndrome. Pediatr Nephrol September 18, 2008 [epub ahead of print]
29. Kavanagh D, Richards A, Fremeaux-Bacchi V, Noris M, Goodship T, Remuzzi G, Atkinson JP: Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2: 591-596, 2007
30. Donne RL, Abbs I, Barany P, Elinder CG, Little M, Conlon P, Goodship TH: Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am J Kidney Dis 40: E22, 2002
31. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L: Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J Am Soc Nephrol 15: 787-795, 2004 (Pubitemid 38294810)
32. Olie KH, Florquin S, Groothoff JW, Verlaak R, Strain L, Goodship TH, Weening JJ, Davin JC: Atypical relapse of hemolytic uremic syndrome after transplantation. Pediatr Nephrol 19: 1173-1176, 2004 (Pubitemid 39317527)
33. Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, Weening JJ, Davin JC: Posttransplantation cytomegalovirus- induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: Successful treatment with intensive plasma exchanges and ganciclovir. Am J Kidney Dis 45: e12-e15, 2005 (Pubitemid 40038036)
34. Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, Lopez-Trascasa M, Rodriguez de Cordoba S, Sanchez-Corral P: Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68: 478-484, 2001 (Pubitemid 32147816)
35. Gerber A, Kirchhoff-Moradpour AH, Obieglo S, Brandis M, Kirschfink M, Zipfel PF, Goodship JA, Zimmerhackl LB: Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatr Nephrol 18: 952-955, 2003 (Pubitemid 37121633)
36. Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B: Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. Am J Kidney Dis 45: 415-421, 2005 (Pubitemid 40431070)
37. Nathanson S, Ulinski T, Fremeaux-Bacchi V, Deschenes G: Secondary failure of plasma therapy in factor H deficiency. Pediatr Nephrol 21: 1769-1771, 2006 (Pubitemid 44390844)
38. Evans HM, McKiernan PJ, Kelly DA: Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 79: 1575-1580, 2005
39. Herzog D, Martin S, Turpin S, Alvarez F: Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 81: 672-677, 2006
40. Alper CA, Johnson AM, Birtch AG, Moore FD: Human C'3: Evidence for the liver as the primary site of synthesis. Science 163: 286-288, 1969
41. 3 Month and 1 Year Patient Survival for Kidney-Liver Transplants from January 1, 2005 to June 30, 2007 First Transplants Only, analyses prepared by the Scientific Registry of Transplant Recipients (SRTR), under contract with the US Department of Health and Human Services, May 31, 2008
42. Bellamy MC, Gedney JA, Buglass H, Gooi JH: Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation. Liver Transpl 10: 273-278, 2004 (Pubitemid 38240127)
43. Scoazec JY, Borghi-Scoazec G, Durand F, Bernuau J, Pham BN, Belghiti J, Feldmann G, Degott C: Complement activation after ischemia-reperfusion in human liver allografts: Incidence and pathophysiological relevance. Gastroenterology 112: 908-918, 1997 (Pubitemid 27113817)
44. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD: Antithrombotic therapy in children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 645S-687S, 2004 (Pubitemid 39297967)
45. Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, Skerka C, Jokiranta TS, Meyers K, Wagner E, Robitaille P, Esparza-Gordillo J, Rodriguez de Cordoba S, Zipfel PF, Goodship TH: De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat 27: 292-293, 2006
46. Vaziri-Sani F, Holmberg L, Sjoholm AG, Kristoffersson AC, Manea M, Fremeaux-Bacchi V, Fehrman-Ekholm I, Raafat R, Karpman D: Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 69: 981-988, 2006 (Pubitemid 43372172)
47. Flechner SM, Kobashigawa J, Klintmalm G: Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22: 1-15, 2008
48. Kwon T, Dragon-Durey MA, Macher MA, Baudouin V, Maisin A, Peuchmaur M, Fremeaux-Bacchi V, Loirat C: Successful pretransplant management of a patient with anti- factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant 23: 2088-2090, 2008